Convatec Group PLC (CTEC) Earnings Call Transcripts

Convatec Group PLC's Latest Earnings Call - May 21, 2026

In the first four months of 2026, Convatec Group PLC (CTEC:GB) reported organic revenue growth of 4.8% excluding InnovaMatrix, which was a slight headwind. The company is on track to meet its full-year guidance of 5% to 7% organic revenue growth, with reported revenue growth of 5.5% aided by favorable FX translation. Management reiterated their confidence in achieving an adjusted operating margin of at least 23% and double-digit EPS growth for the year, signaling a resilient business despite macroeconomic challenges.

Reported metrics

Guidance from management

Management maintained their guidance for 5% to 7% organic revenue growth excluding InnovaMatrix for the full year 2026, with an adjusted operating margin of at least 23%. They expect double-digit EPS growth and strong performance in Infusion Care moving forward.

What management said

Good morning, everybody, and welcome to our AGM trading update call. The headline is that we've made a good start to the year with results for the first 4 months in line with expectations. We're on track to deliver our 2026 guidance. I'm going to hand over to our CFO, Fiona, to present those results. Then I'll make some brief comments on strategic progress afterwards, and we'll take any questions that you have.

Thank you, Graham. So we are on track to deliver our full year guidance of 5% to 7%, excluding InnovaMatrix for the full year. We have delivered 4.8%, excluding InnovaMatrix for the first 4 months. And so we will continue to build that revenue growth through the year. I think your assumption is reasonable for the first half. For the margin growth, as I said, we would expect to be around flat to the first half 2025 on...

What analysts pressed on

Analysts expressed concerns regarding the potential impact of inflation on margins and the uncertainty surrounding InnovaMatrix's market recovery. There were questions about the company's ability to maintain margin guidance in light of historical performance and current economic conditions.

Main topics on the call

• Revenue Growth Consistency — Convatec achieved organic revenue growth of 4.8% excluding InnovaMatrix, with a reported growth of 5.5% due to favorable FX. Management stated, "We are on track to deliver our guidance of 5% to 7% organic revenue growth ...
• InnovaMatrix Impact — InnovaMatrix represented a 3% headwind to group growth but is expected to contribute around $20 million in revenue, significantly weighted to the second half of the year. Management noted, "2026 will be the low point in ...
• Product Launches and Market Position — The company is launching five new products in Advanced Wound Care, which management believes will drive future growth. CEO Jonathan Mason mentioned, "We have been planning for it for years," indicating a strong pipeline.
• Margin Guidance Confidence — Management maintained their guidance for an adjusted operating margin of at least 23%, despite facing FX headwinds. CFO Fiona Ryder stated, "We are confident in delivering our full year guidance as our productivity and s...

Read the full Convatec Group PLC transcript (May 21, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 25 Convatec Group PLC earnings call transcripts on record, spanning February 28, 2020 to August 4, 2026. Based on this history, Convatec Group PLC reports quarterly. The most recent call on file is dated August 4, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

CTEC

Exchange

LSE

Country

GB

Sector

Health Care

Industry

Health Care Equipment and Supplies

Calls on record

25

First call

February 28, 2020

Most recent

August 4, 2026

Reporting cadence

quarterly